Home           |           About Us           |           Register Free           |           Events and Conferences           |           Contact Us

AlphaRx is an emerging drug delivery company engaged in the development and market of therapeutic products using proprietary drug delivery technologies.

AlphaRx's primary competence is in the development of novel drug formulations for compounds that are poorly soluble in water or have yet to be administrable to the human body with an acceptable delivery method.

Website : www.alpharx.com

Coley Pharmaceutical Group is the leader in the discovery and development of a breakthrough class of immunotherapy drug candidates with broad clinical and commercial potential.

Website : www.coleypharma.com

Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions and acute injury. We are listed on both the TSX and NASDAQ stock exchanges (NASDAQ: ANPI, TSX: ANP).

Website : www.angiotech.com

Chiron.com is the place to find information on products and services provided by the Chiron business unit of Novartis Vaccines and Diagnostics. We recently updated the site to enhance your experience, improving functionality, accessibility and style.

Website : www.chiron.com

Cardiome Pharma Corp. is a product-focused cardiovascular drug development company with two late-stage clinical drug programs focused on atrial arrhythmia (intravenous and oral dosing), a Phase 1 program for GED-aPC, an engineered analog of recombinant human activated Protein C, and a pre-clinical program directed at improving cardiovascular function.

Website : www.cardiome.com

Victhom develops human bionic devices. Our objective is to improve the quality of life of people suffering from physical dysfunctions.

When considered appropriate, Victhom acquires technologies and businesses that provide the company with a strategic advantage in the pursuit of its development programs and corporate objectives.

Website : www.victhom.com

Viventia Biotech Inc. is a privately held biopharmaceutical company specializing in the discovery and development of a new generation of advanced monoclonal antibody products designed to offer safer, more beneficial therapies for those who suffer from cancer. Our lead product candidate Proxinium™ is in multiple clinical studies, including a Phase III clinical trial for the treatment of head and neck cancer.

Website : www.viventia.com

Amorfix is an emerging theranostics company focused on the diagnosis and treatment of neurodegenerative diseases, where aggregated misfolded proteins (AMP) are prevalent. These include Transmissible Spongiform Encephalopathies (TSE), such as Bovine Spongiform Encephalopathy (BSE) and the human form variant Creutzfeldt-Jakob Disease (vCJD), as well as degenerative diseases such as Alzheimer's Disease (AD), Amyotrophic Lateral Sclerosis (ALS) and Parkinson's Disease (PD).

Website : www.amorfix.com

DRAXIS Health Inc. is a rapidly growing company providing specialty pharmaceutical products globally in three categories: sterile products, non-sterile products and radiopharmaceuticals. Sterile products include liquid and freeze-dried (lyophilized) injectables, sterile ointments and sterile creams. Specialty non-sterile products are produced as tablets, ointments, liquids and creams.

Website : www.draxis.com

ConjuChem Biotechnologies Inc. is a publicly traded Canadian biotechnology company dedicated to the discovery of novel therapeutics with an initial focus on diabetes.

Website : www.conjuchem.com

Caprion’s leading and proprietary proteomics discovery technologies - CellCarta® - enable the discovery of novel targets for therapeutics development and the identification of novel protein biomarkers that can significantly reduce risk and enhance clinical development productivity and decision making in pharmaceutical research.

Website : www.caprion.com

Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or even save lives.

Website : www.amgen.com

Biopharmacopae specializes in the discovery and development of bioactive products from plants. Plants have been historically and remain the world's best source of active ingredients for health care products and drugs.

Using a suite of technologies including enzymology, cell biology and chemistry, our team of scientists have developed a proprietary platform technology that can identify key plant extracts in a short time overcoming technical difficulties that have prohibited widespread discovery of active ingredients from plants.

Website : www.biopharmacopae.com

As a global, broad-based health care company, Abbott build upon their internal scientific expertise to bring new products to market. Their work across their broad lines of business gives them a wealth of knowledge, understanding and capabilities in a number of health areas. This expertise helps them to advance medical science, enabling people to live healthier lives.

Website : www.abbott.com

Wyeth is a global leader in pharmaceuticals, consumer health care products, and animal health care products.

Wyeth improves the lives of millions of people around the world with its outstanding products. And new, innovative medicines are on the way. With research and development (R&D) programs focused on small molecules, vaccines and biotechnology, Wyeth is exploring more than 60 new therapies for medical conditions such as diabetes, breast cancer, multiple sclerosis, HIV, Alzheimer’s disease and schizophrenia.

Website : www.wyeth.com